GlassScriptPhysician profile
David M Fitzgerald
NPI 1437134475
$7,464.18
in general payments reported to CMS, 2019-2025
10 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,235 · 2020: $203 · 2021: $232 · 2022: $639 · 2023: $1,590 · 2024: $402 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,510 · Travel and Lodging: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,510.27 |
| Travel and Lodging | $644.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,938.94 | 2019-2020 | |
| Medtronic, INC. | $2,017.41 | 2021-2025 | Diamondtemp Bidirectional Ablation Catheter, Aurora Ev-Icd Mri Surescan, Micra |
| Boston Scientific Corporation | $1,063.87 | 2019 | |
| Abbott Laboratories | $648.37 | 2020-2025 | Sensitherm Multi, Ensite Precision, Aveir |
| Medical Device Business Services, INC. | $352.91 | 2019 | |
| Biosense Webster, INC. | $337.78 | 2022-2025 | Carto 3, Qdot Micro Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.90 | 2019-2024 | Lifevest |
| Angiodynamics, INC. | $28.13 | 2025 | Angiovac |
| Edwards Lifesciences Corporation | $19.05 | 2021 | |
| Elutia, INC. | $18.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fitzgerald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.